BioCryst Pharmaceuticals | BCRX - Rentabilidad Por Dividendo

Precio De Mercado
9.56
Cambio Diario
-0.33 -3.34%
Mensual
12.60%
Anual
40.18%
Q2 Expectativa
9.30




Dy Cambio Fecha
BioCryst Pharmaceuticals 0 0 2025-03
Chugai Pharma 1.3 0.36 2025-12
Daiichi Sankyo 2.06 0.25 2025-12
DBV Technologies USD 0 0 2024-08
Enanta Pharmaceuticals 0 0 2025-03
Gilead Sciences 2.58 0.25 2025-12
GlaxoSmithKline 4.57 1.52 2025-12
Glaxosmithkline GBP 4.47 0.32 2025-12
Karyopharm Therapeutics 0 0 2025-03
Regeneron Pharmaceuticals 0.46 0.01 2025-12
Roche Holding 2.96 0.8 2025-12